Research at Radboud University Medical Center on 21 antidepressants found that escitalopram, agomelatine and duloxetine were the most effective long term, NL Times reported. The three drugs reportedly outperformed fluoxetine, the active ingredient in Prozac.
According to the findings, the three came out top for sustained recovery and a reduced chance of relapse. That partly clashes with Dutch guidance, which lists citalopram, escitalopram, sertraline and fluoxetine among the preferred options; the result partly contradicted this.
The analysis reviewed 115 earlier studies with over 30,000 participants, comparing results at four to eight weeks and at six to 12 months.
Roughly 1.2 million people in the Netherlands use antidepressants, according to the figures. Around half a million have taken the same drug for more than two years, and some 300,000 begin treatment each year.
Paul van Haaren, the first author, told RTL that the key issue is which antidepressant most helps people with a first episode of depression recover without relapsing.
Eric Ruhé, a co-researcher, said that for every eight people given antidepressants, one more improves thanks to escitalopram.
Ruhé said the finding applies to people starting medication, not to patients already doing well, and that personal factors still matter.



